Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Devices Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software

Published: Tuesday, November 27, 2012
Last Updated: Tuesday, November 27, 2012
Bookmark and Share
Software is compliant with CFR Part 11 requirements.

Molecular Devices, LLC, announced the launch of SoftMax® Pro 6 GxP Software, for data acquisition and analysis from microplate readers in regulated environments. The software additionally supports the SpectraMax® Paradigm® Multi-Mode Detection Platform and FilterMax™ F3/F5 Microplate Readers.

SoftMax Pro 6 GxP Software facilitates easy upgrades for existing users from previous software versions with its unique “plug-in” feature that allows existing databases to be integrated without the need to re-establish and revalidate the whole system, thereby decreasing time and resources needed for this stage which can be costly and inefficient. A custom-designed validation package supports the software such as printable IQ-OQ worksheets, extensive tests for data analysis features, easy-to-follow instructions and ready-to-use sample data to streamline the software validation process making it easy and fast to validate this powerful data analysis tool.

The new software package also incorporates editors to enable easy creation of intricate protocols such as the Syntax Helper formula writing tool, and a robust data analysis package with over 15 curve fits that include: validated Parallel Line Analysis (PLA), 4-P, 5-P logistics, independent plot weighting, confidence interval calculations, and parameter dependencies chart, effectively eliminating the need for additional software purchase and validation.

The software is tightly aligned to FDA’s 21 CFR Part 11 guidance for electronic signature and electronic record. Security is ensured through controlled access and automatic lockout systems, while the document-based audit trail enables easy tracking and recording of actions, and granular user permissions control. A centralized administration system and flexible software design allows multiple administrators and remote management of user accounts, a great benefit to larger and multi-site organizations. Password-aging, log-on failure lockout, automatic idle log out, the ability to be used off-line and guest access are additional secure, compliance features that are unique to this software.

“Since its introduction, SoftMax Pro GxP Software has become an industry standard for microplate reader data acquisition and analysis in controlled environments,” said Brian Quast, BioResearch Director, Molecular Devices. “The upgrade to SoftMax Pro 6 GxP ensures we continue to offer the most comprehensive validation tools for our customers.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Devices Partners with Roche
Partnership will develop custom Ruthenium Nano-TRF Detection Platform.
Thursday, November 06, 2014
Molecular Devices Becomes Global Distributor of IonFlux
Molecular Devices makes deal with Fluxion Biosciences to distribute their automated electrophysiology systems and associated products.
Tuesday, May 28, 2013
Molecular Devices Forms Scientific Advisory Board
Multidisciplinary team will guide product and application development to deliver maximum value to customers.
Thursday, December 27, 2012
Molecular Devices to attend ADME & Predictive Toxicology Europe
Company is to showcase its SpectraMax® Paradigm® microplate reader during the European conference in Munich, Germany, 13-14 March 2012.
Wednesday, February 29, 2012
Molecular Devices Awarded Patent for Population Patch Clamp Recording Technique
The parallel recording technique measures ionic currents from a population of cells, rather than single cells, on planar patch clamp systems and enhances ion channel assay success rates to near 100%.
Tuesday, January 10, 2012
Registration opens for RNAi and High Content Imaging 2011
Molecular Devices Inc. announces that they have opened registration for its RNAi & High Content Imaging Symposium 2011, to be held at the Oxford Spires Four Pillars, Oxford on 1st April 2011.
Tuesday, February 08, 2011
Molecular Devices Launches New Products & Customer-Focused Brand at Society for Biomolecular Sciences Meeting
New IonWorks Barracuda™ Automated High-Speed Patch Clamp System & AquaMax® 2000/4000 Microplate Washer 96 Cell-Wash Head
Thursday, April 08, 2010
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!